Status:
COMPLETED
Dexmedetomidine Versus Nalbuphine as an Adjuvant to Intrathecal Bupivacaine
Lead Sponsor:
Mansoura University
Conditions:
Analgesia
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
Spinal anesthesia is the most consistent block for lower abdomen and lower limb surgical procedures. Over years many drugs have been used as an additive to spinal anesthesia in order to prolong the du...
Detailed Description
This prospective, double blinded, randomized, controlled study will be held to compare Nalbuphine versus Dexmedetomidine as adjuvants to intrathecal Bupivacaine in spinal anesthesia in patients underg...
Eligibility Criteria
Inclusion
- Age between 20 and 60 years.
- Both genders.
- Patients scheduled for lower limb orthopedic surgeries under spinal anesthesia.
- American society of anesthesiologists (ASA) class I or II.
Exclusion
- Patient refusal.
- Age \<20 or \>60 years.
- Contraindications to spinal anesthesia (e.g. bleeding diathesis, spinal cord deformities, infection at injection site).
- History of allergy to any of the study medications.
- Cases with severe cardiac, renal, or hepatic disease.
- American society of anesthesiologists (ASA) class III, IV.
- Patient on regular analgesics or opioid abuse.
- Patient with peripheral neuropathy.
Key Trial Info
Start Date :
June 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 12 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05347173
Start Date
June 21 2022
End Date
March 12 2024
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University-Emergency hospital-ICU
El Dakahlia, Mansoura, Egypt, 35511